Quarterly report pursuant to Section 13 or 15(d)

Business Combinations - Additional Information (Detail)

v3.22.2.2
Business Combinations - Additional Information (Detail) - USD ($)
 6 Months Ended 12 Months Ended
Jun. 10, 2022
Mar. 01, 2022
Sep. 14, 2021
Jun. 30, 2022
Dec. 31, 2021
VocaliD [Member]          
Business Acquisition [Line Items]          
Total consideration $ 3,394,000        
Cash payment 1,609,000        
Deferred consideration 1,785,000        
Tax deductible goodwill, acquisition 0        
Deferred tax liability 663,000        
VocaliD [Member] | Developed Technology [Member]          
Business Acquisition [Line Items]          
Identifiable intangible assets acquired, amount $ 2,700,000        
Estimated useful lives 3 years        
VocaliD [Member] | General and Administrative Expense [Member]          
Business Acquisition [Line Items]          
Acquisition related expenses $ 200,000        
March 2022 Acquisition [Member]          
Business Acquisition [Line Items]          
Total consideration   $ 5,844,000      
Cash payment   1,500,000      
Deferred consideration   2,707,000      
Tax deductible goodwill, acquisition   2,842,000      
Identifiable intangible assets acquired, amount   3,000,000      
Equity consideration at closing   1,929,000      
Settlement of pre-existing receivable   976,000      
Acquired cash   684,000      
Contingent earnout   3,015,000      
Transaction cost   $ 270,000      
March 2022 Acquisition [Member] | Maximum [Member]          
Business Acquisition [Line Items]          
Estimated useful lives   10 years      
March 2022 Acquisition [Member] | Minimum [Member]          
Business Acquisition [Line Items]          
Estimated useful lives   2 years      
March 2022 Acquisition [Member] | General and Administrative Expense [Member]          
Business Acquisition [Line Items]          
Acquisition related expenses   $ 270,000      
Pandologic Ltd [Member]          
Business Acquisition [Line Items]          
Contingent earnout     $ 44,900,000    
Pandologic Ltd [Member] | Contingent Consideration          
Business Acquisition [Line Items]          
Contingent earnout     39,512,000    
Pandologic Ltd [Member] | General and Administrative Expense [Member]          
Business Acquisition [Line Items]          
Acquisition related expenses         $ 2,161,000
Pandologic Ltd [Member] | Recognized in Compensation Expense Within General and Administrative Expense [Member]          
Business Acquisition [Line Items]          
Contingent earnout     5,388,000    
Pandologic Ltd [Member]          
Business Acquisition [Line Items]          
Total consideration     135,563,000    
Cash payment     58,733,000    
Identifiable intangible assets acquired, amount     92,000,000    
Equity consideration at closing     31,500,000    
Deferred tax liability     $ 12,686,000 $ 0  
Deferred tax assets       0  
Goodwill not deductible for tax purposes       33,111,000  
Deferred tax assets, valuation allowance       $ 0  
Pandologic Ltd [Member] | Israeli [Member]          
Business Acquisition [Line Items]          
Tax rate     23.00% 12.00%  
Pandologic Ltd [Member] | Maximum [Member]          
Business Acquisition [Line Items]          
Estimated useful lives       7 years  
Pandologic Ltd [Member] | Minimum [Member]          
Business Acquisition [Line Items]          
Estimated useful lives       4 years  
Pandologic Ltd [Member] | Common Stock [Member]          
Business Acquisition [Line Items]          
Consideration equity interest issued number of shares       352,330  
Pandologic Ltd [Member] | Developed Technology [Member]          
Business Acquisition [Line Items]          
Identifiable intangible assets acquired, amount     $ 20,000,000    
Estimated useful lives     4 years    
Stock Purchase Agreement [Member] | VocaliD [Member]          
Business Acquisition [Line Items]          
Business acquisition, effective date of acquisition Jun. 10, 2022        
Business acquisition, percentage of ownership interests acquired 100.00%        
Business acquisition, name of acquired entity VocaliD        
Business acquisition, date of acquisition agreement Jun. 10, 2022        
Total consideration $ 3,394,000        
Cash payment 1,609,000        
Deferred cash payment 2,000,000        
Deferred consideration $ 1,785,000        
Securities Purchase Agreement [Member] | March 2022 Acquisition [Member]          
Business Acquisition [Line Items]          
Business acquisition, effective date of acquisition   Mar. 01, 2022      
Business acquisition, percentage of ownership interests acquired   100.00%      
Business acquisition, date of acquisition agreement   Mar. 01, 2022      
Total consideration   $ 5,844,000      
Cash payment   1,500,000      
Deferred cash payment   3,000,000      
Deferred consideration   2,707,000      
Settlement of pre-existing receivable   (976,000)      
Acquired cash   684,000      
Securities Purchase Agreement [Member] | March 2022 Acquisition [Member] | Maximum [Member]          
Business Acquisition [Line Items]          
Contingent earnout consideration   4,500,000      
Securities Purchase Agreement [Member] | March 2022 Acquisition [Member] | Common Stock [Member]          
Business Acquisition [Line Items]          
Equity consideration at closing   $ 1,929,000      
Consideration equity interest issued number of shares   116,550      
Agreement and Plan of Merger [Member] | Pandologic Ltd [Member]          
Business Acquisition [Line Items]          
Business acquisition, effective date of acquisition     Sep. 14, 2021    
Business acquisition, percentage of ownership interests acquired     100.00%    
Business acquisition, name of acquired entity     PandoLogic    
Business acquisition, date of acquisition agreement     Jul. 21, 2021    
Total consideration     $ 135,563,000    
Cash payment     58,733,000    
Agreement and Plan of Merger [Member] | Pandologic Ltd [Member] | Maximum [Member]          
Business Acquisition [Line Items]          
Contingent earnout consideration     65,000,000    
Agreement and Plan of Merger [Member] | Pandologic Ltd [Member] | Common Stock [Member]          
Business Acquisition [Line Items]          
Equity consideration at closing     $ 31,500,000    
Consideration equity interest issued number of shares     1,704,822